Sino-Global Shipping America, Ltd. (NASDAQ:SINO)
Sino-Global Shipping America, Ltd. (NASDAQ:SINO) represented a move of 0 percent or $0.07 per share and closed its previous day trading session at $0.98. 0 Shares were traded in the last trading session with an Average Volume of 239.07 Million Shares. The stock currently has a Market Capitalization of 13 Million.
Registered in the United States in 2001 and operating in Mainland China, Sino-Global is a leading, non-state-owned provider of high-quality shipping services. With local branches in five of China’s 76 ports and contractual arrangements in all those where it does not have branch offices, Sino-Global is able to offer efficient, high-quality services to shipping companies entering Chinese ports. Sino-Global provides comprehensive yet customized shipping services to ship owners, operators and charters including intelligence, planning, real-time analysis and on-the-ground implementation and logistics support. Sino-Global has achieved both ISO9000 and UKAS certifications.
The stock traded between $0.880 and $2.830 over 1-Year time period showing its price to sales ratio of 0.54. Sino-Global Shipping America, Ltd. (NASDAQ:SINO) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-12.74 and 200-Day Simple Moving Average of $-19.54. Its Price to Free Cash Flow is 0 and Price to Book of 0.55.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Sino-Global Shipping America, Ltd. (NASDAQ:SINO) reported its Actual EPS of $-0.1/share. The analysts offering Earnings Estimates for the company were believing that Sino-Global Shipping America, Ltd. could bring EPS of $0.06/share. The difference between Actual EPS and Estimated EPS was -0.16 Percent. Thus showing an Earnings Surprise of -266.7 Percent.
Synthetic Biologics, Inc (NYSE:SYN)
In the last trading session, Synthetic Biologics, Inc (NYSE:SYN) added its value by 0% closing at the price of $0.73. The stock currently has market capitalization of 9.61 Million, with average volume of 1.12 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently Synthetic Biologics, Inc (NYSE:SYN) is showing beta of 2.37. This particular value of beta suggests that Synthetic Biologics, Inc (NYSE:SYN) has historically moved 237% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for Synthetic Biologics, Inc (NYSE:SYN) is at $3.89.
The stock currently has RSI of 23.29. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
Synthetic Biologics, Inc. is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses. The Company is engaged in developing product candidates to treat pulmonary arterial hypertension, relapses in multiple sclerosis, cognitive dysfunction in multiple sclerosis, fibromyalgia and amyotrophic lateral sclerosis. Synthetic Biologics, Inc., formerly known as Adeona Pharmaceuticals, Inc., is headquartered in Ann Arbor, Michigan.
Synthetic Biologics, Inc (NYSE:SYN) topped its 52-week high price of $22.750 on 12/07/17 and 52-Week Low Price of $ 0.700 on 11/29/18. The Stock currently has P/E (price to earnings ttm) of 0.19 and Weekly volatility of 6.41% and monthly volatility of 7.67% respectively.